CryoPort Inc (CYRX)

[CYRXorbust]

Clinical Trial Breakdown

Phase I 100
Phase II 105
Phase III 31

what I find odd is that Phase II has more than Phase I. you might think that we would need a considerably larger # of phase 1s to keep the pipeline moving. Are we picking up studies that passed Phase I but were using other vendors? Are CAR-T therapies seeing extremely high success rates going from Phase I to II. If so then our Phase II pipeline is going to be robust.